The British government expects a delay in the delivery of flu shot stocks, raising concerns for vulnerable people at the start of the flu season.
The flu jab is usually given first to high-risk groups such as those over 65 years and those with respiratory and chronic conditions, reports the Independent.
The delay is blamed on manufacturers being forced to switch to growing a flu strain for the vaccine called 161B after another strain failed to grow, the newspaper said.
The Health Ministry, however, said the situation is better than what had been predicted in June. It also said some hospital may have to share their stocks. The department said there would be enough doses eventually but that some patients may have to wait to get their shots.
A spokesman for the British Medical Association said, "Late delivery of vaccines means immunization clinics will in many areas start later than normal."
Copyright 2006 by United Press International
Related stories:
Political borders, health-care issues complicate pandemic planning
Panic, staffing issues and geographic boundaries are some of the challenges that public health experts need to address as they plan for a possible influenza pandemic, according to a new report from Purdue University.
Penn animal study identifies new DNA weapon against avian flu
Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus. This approach could allow for the build up of vaccine reserves that could be easily and effectively dispensed in case of an epidemic. This study was published last week in
PLoS ONE.
New vaccine may give long-term defense against deadly bird flu and its variant forms
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.
Modern matron struggling to fulfil role as leader
Experts at The University of Nottingham say ‘modern matrons’ — with their managerial and entrepreneurial skills — are struggling to fulfil their role as leader, and this remains a major challenge in a crucially important area of healthcare.
Microneedles Could Replace Syringe
The common needle phobia and painful injections could soon be a thing of the past, thanks to a revolutionary new drug-delivery technique developed by a team at the Georgia Institute of Technology, US. The long-practiced method of drug administration has up to now involved the use of hypodermic needles but they have many drawbacks, including pain, risk of infection, and the need for trained staff to perform the injection.
Microneedles enhance drug administration through skin
In what is believed to be the first peer-reviewed study of its kind involving human subjects, researchers at the University of Kentucky College of Pharmacy and the Georgia Institute of Technology have demonstrated that patches coated on one side with microscopic needles can facilitate transdermal delivery of clinically-relevant doses of a drug that normally cannot pass through the skin.
Large avian flu outbreaks more likely to involve duck meat industry, experts find
Scientists at the University of Liverpool have found that 73% of avian flu outbreaks in the UK would not spread beyond the initial infected farm, but larger outbreaks are more likely to involve the duck meat industry.
Protein enhances lethality of influenza virus
Often called the most devastating epidemic in the recorded history of the world, the 1918 influenza virus pandemic was responsible for more than 40 million deaths across the globe. The incredible lethality of the 1918 flu strain is not well understood, despite having been under intense scrutiny for many years.